Press release
Anal Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
Anal Cancer Pipeline
Key Takeaways from the Anal Cancer Pipeline Report
• DelveInsight's Anal Cancer pipeline report depicts a robust space with 6+ active players working to develop 6+ pipeline therapies for Anal Cancer treatment.
• The leading companies working in the Anal Cancer Market include Incyte Corporation, Merck & Co, Novartis Pharmaceuticals, Advaxis, Boehringer Ingelheim, Sumitomo Pharma Oncology Inc., Advaxis Inc., The Emmes Company LLC, BioMimetix JV LLC, Corregene Biotechnology Co. Ltd, Inovio Pharmaceuticals, Novartis, Hoffmann-La Roche, Genentech Inc., Amgen, and others.
• Promising Anal Cancer Pipeline Therapies in the various stages of development include Pembrolizumab, TP-1454 Monotherapy, Axalimogene Filolisbac, Cetuximab, Cisplatin, Fluorouracil, Cetuximab, Mitomycin C, 5-Fluoruracil, Radiotherapy, and others.
• On May 2023, Centre Hospitalier Universitaire de Besancon announced a study of Phase 2 Clinical Trials for Biopsy. Squamous cell carcinoma of the anus (SCCA) is a rare cancer, however its incidence is increasing worldwide. SCCA is mostly induced by human papillomavirus (HPV) infections (high-risk types such as HPV-16 and -18) and HPV-related oncoproteins (E6 and E7) are expressed in more than 90% of cases.
• On June 2023, Dana-Farber Cancer Institute announced a study of Phase 2 Clinical Trials for Pembrolizumab. This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug is being studied.
Request a sample and discover the recent advances in Anal Cancer Treatment Drugs @ Anal Cancer Pipeline Report- https://www.delveinsight.com/report-store/anal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Anal Cancer pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Anal Cancer drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Anal Cancer clinical trial landscape.
Anal Cancer Overview
Anal cancer is a rare condition, although its incidence has been increasing over the past several decades, particularly in women. The majority of anal cancers are squamous cell cancers and are linked with human papillomavirus (HPV) infection.
Find out more about Anal Cancer Treatment Drugs @ Drugs for Anal Cancer Treatment- https://www.delveinsight.com/sample-request/anal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Anal Cancer Emerging Drugs Profile
• PDS0101: Merck & Co
• Avelumab: Merck KGaA
Anal Cancer Pipeline Therapeutics Assessment
There are approx. 6+ key companies which are developing the therapies for Anal Cancer. The Anal Cancer companies which have their Anal Cancer drug candidates in the most advanced stage, i.e. phase II include, Merck & Co.
Learn more about the emerging Anal Cancer Pipeline Therapies @ Anal Cancer Clinical Trials Assessment- https://www.delveinsight.com/sample-request/anal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Anal Cancer Pipeline Report
• Coverage- Global
• Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Anal Cancer Companies- Merck & Co, Novartis Pharmaceuticals, Advaxis, Boehringer Ingelheim, Sumitomo Pharma Oncology Inc., Advaxis Inc., The Emmes Company LLC, BioMimetix JV LLC, Corregene Biotechnology Co. Ltd, Inovio Pharmaceuticals, Novartis, Hoffmann-La Roche, Genentech Inc., Amgen, and others.
• Anal Cancer Pipeline Therapies- Pembrolizumab, TP-1454 Monotherapy, Axalimogene Filolisbac, Cetuximab, Cisplatin, Fluorouracil, Cetuximab, Mitomycin C, 5-Fluoruracil, Radiotherapy, and others.
Dive deep into rich insights for new drugs for Anal Cancer Treatment, Visit @ Anal Cancer Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/anal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Anal Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Anal Cancer- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Retifanlimab: Incyte Corporation
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. PDS0101: Merck & Co
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Drug Name: Company Name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Anal Cancer Key Companies
21. Anal Cancer Key Products
22. Anal Cancer- Unmet Needs
23. Anal Cancer- Market Drivers and Barriers
24. Anal Cancer- Future Perspectives and Conclusion
25. Anal Cancer Analyst Views
26. Anal Cancer Key Companies
27. 27. Appendix
For further information on the Anal Cancer Pipeline therapeutics, reach out to Anal Cancer Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/anal-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Important Published Links-
https://evening-newss.mn.co/members/20271728
https://omind.mn.co/members/20271735
https://shop1606.mn.co/posts/45816438
https://council-of-light.mn.co/posts/45816468
https://chanspirations.mn.co/posts/45816726
https://hulu-com-forgot.mn.co/posts/45816832
https://bucketseems-news.mn.co/members/20271966
https://sentinels.mn.co/members/20272156
https://akademe.mn.co/posts/navigating-the-acne-vulgaris-market-trends-treatments-and-technological-advances
https://tc-2345.mn.co/posts/45818004
https://gene-keys-genealogy.mn.co/posts/45818150
https://take-your-phone.mn.co/posts/45818381
https://digitaldrip.mn.co/posts/45818561
https://network-24921.mn.co/posts/45818644
https://friends-of-zizira.mn.co/members/20272206
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653
https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.uplabs.com/dennydones9
https://www.zazzle.com/mbr/238605385879691977
https://independent.academia.edu/HavenSmith2
https://play.eslgaming.com/player/19736877/
https://creators.audiomack.com/dennydones1
https://piano.masto.host/@dennydones9
https://tech4goodwales.mn.co/posts/the-evolving-landscape-of-the-major-depressive-disorder-market
https://worldletinews.mn.co/members/20156129
https://community.greeka.com/users/dennydones9
https://www.exchangle.com/dennydones9
https://old.meneame.net/user/dennydones9
https://gsap.com/community/profile/159086-denny-dones/
https://www.pling.com/u/dennydones9/
https://shaunbook.mn.co/posts/type-1-diabetes-market-size-forecast-and-outlook-2032
https://zip-launchpad.mn.co/posts/45579349
https://dj-club-sf.mn.co/posts/45579415
https://wwwpreparatorianis.mn.co/posts/45579543
https://www.projectnoah.org/users/dennydones9
https://naijases.mn.co/posts/type-1-diabetes-market-future-trends-and-opportunities
https://indicate.mn.co/posts/45580238
https://linkasia.mn.co/posts/45580415
https://playhq.mn.co/posts/45580609
https://coco-quinn.mn.co/posts/45580757
https://aeros.mn.co/posts/45751762
https://churecipe.mn.co/posts/45751826
https://itravel.mn.co/members/20248979
https://hubvin.mn.co/posts/45752020
https://drujrake.mn.co/posts/45752126
https://together.mn.co/posts/45752522
https://bipolarjungle.mn.co/posts/45752571
https://mossfon.mn.co/posts/45752666
https://create-lifestyle.mn.co/posts/45753329
https://gelardas.mn.co/members/20249381
https://bloby.mn.co/posts/45753578
https://cic-mun.mn.co/posts/45753710
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anal Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated) here
News-ID: 3300779 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Anal
Evolving Market Trends In The Anal Fissure Treatment Industry: The Influence Of …
The Anal Fissure Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anal Fissure Treatment Market Size During the Forecast Period?
The market size for anal fissure treatment has seen robust growth in the past few years. The market size will escalate…
Anal Fistula Treatment Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Anal Fistula Treatment Market was valued at USD 624.06 Million in 2020 and is projected to reach USD 857.69 Million by 2028, growing at a CAGR of 4.06% from 2021 to 2028.
Market Overview for Anal Fistula Treatment Market
Anal Fistula Treatment Market OverviewThe global market for anal fistula treatment is witnessing significant growth driven by rising incidences of anal fistulas worldwide. Anal fistulas, characterized by abnormal channels between…
Maximizing Momentum: Visionaries and the Trans-anal Irrigation Market
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, has recently published a comprehensive report on the Trans-anal Irrigation Market. This report aims to provide a complete overview of the market, offering the latest updated information on various crucial aspects that are expected to impact Market trends and performance during the forecast period.
𝐆𝐚𝐢𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐓𝐫𝐚𝐧𝐬-𝐚𝐧𝐚𝐥 𝐈𝐫𝐫𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐃𝐅 𝐧𝐨𝐰 @ https://growthmarketreports.com/request-sample/5230?utm=Openpr
𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐓𝐫𝐚𝐧𝐬-𝐚𝐧𝐚𝐥 𝐈𝐫𝐫𝐢𝐠𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭:
𝐁𝐲 𝐓𝐲𝐩𝐞 …
Anal Fistula Therapeutics Market Research and Forecast 2020-2026
The global anal fistula therapeutics market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Emerging medical tourism is expected to offer an opportunity for the growth of the market. Growing medical tourism has been witnessed in several countries. In Asia, India, Thailand, Singapore, Philippines, and Malaysia, are the major destinations for medical tourism. In India, some crucial factors that are contributing to the growth…
Anal Cancer Market Research, Development, Analytical Forecast to 2027
Anal cancer affects the tissues of the anus, at the end of the gastrointestinal tract. Anal cancer is a lump created by the abnormal and uncontrolled growth of cells in the anus. This type of cancer occurs in people with weakened immune systems, common among the women. It closely relates with some HPV (human papilloma virus) strains. Market for Anal cancer is growing because of growing sexually transmitted diseases, aging…
Global Anal Cancer Market Research Report- Forecast To 2027
Global Anal Cancer Information, by type (Squamous cell carcinomas, Adenocarcinomas, perianal skin cancers, Melanomas and others), by treatment (chemotherapy, radio therapy, surgery and others), by end users (hospitals, clinics, research institutes and others) - Forecast to 2027
Study Objectives of Anal Cancer Market:
• To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Anal Cancer market
• To provide insights…
